Asthma is a common respiratory illness affecting approximately 8% of Americans and is characterized by symptoms of wheeze, cough, and shortness of breath. However, the role played by the body’s endogenous microbial communities (microbiota) has emerged as a new component to this puzzle. Kau et al. discuss how microbial community dynamics promote allergy susceptibility and the potential for microbiota-directed therapeutics in asthma.
Image credit: Wilson NG, et al. (2019)